During the past decade, Whangarei Hospital conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Whangarei Hospital" #1 sponsor was "Antipodean Pharmaceuticals, Inc." with 1 trials, followed by "Population Health Research Institute" with 1 trials sponsored, "Rutgers, The State University of New Jersey" with 1 trials sponsored, "The University of Queensland" with 1 trials sponsored and "UMC Utrecht" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Whangarei Hospital" #1 collaborator was "Berry Consultants" with 2 trials as a collaborator, "Australia and New Zealand Dialysis and Transplant Registry" with 1 trials as a collaborator, "Australian and New Zealand Intensive Care Research Centre" with 1 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator and "Global Coalition for Adaptive Research" with 1 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 24 trials.

According to Clinical.Site data, the most researched conditions in "Whangarei Hospital" are "Anemia" (1 trials), "Breast Cancer" (1 trials), "Chemotherapy-induced Nausea and Vomiting" (1 trials), "Community-acquired Pneumonia, Influenza, COVID-19" (1 trials) and "Endstage Renal Disease" (1 trials). Many other conditions were trialed in "Whangarei Hospital" in a lesser frequency.

Most popular intervention types in "Whangarei Hospital" are "Drug" (5 trials), "Biological" (2 trials), "Other" (2 trials), "Behavioral" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "ARB + DMX-200" (1 trials), "Amoxicillin-clavulanate" (1 trials), "Anakinra" (1 trials) and "Angiotensin Receptor Blockers" (1 trials). Other intervention names were less common.

The vast majority of trials in "Whangarei Hospital" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Whangarei Hospital". undefined are not yet recruiting, 5 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Whangarei Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Whangarei Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".